| BP category | Model 1 | Model 2 | |||||
---|---|---|---|---|---|---|---|---|
 | E/N | HR | (95% CI) | p | HR | (95% CI) | p | |
Total (N = 1448) | SBP < 120 | 41/413 | 1.01 | (0.64–1.58) | 0.96 | 1.05 | (0.67–1.64) | 0.84 |
 | 120 ≤ SBP < 130* | 36/260 | Ref |  |  | Ref |  |  |
 | 130 ≤ SBP < 140 | 60/253 | 1.69 | (1.12–2.56) | 0.013 | 1.40 | (0.92–2.14) | 0.11 |
 | SBP ≥ 140 | 168/522 | 1.84 | (1.28–2.64) | 0.001 | 1.72 | (1.19–2.48) | 0.004 |
Treated (N = 399) | SBP < 120 | 12/52 | 1.55 | (0.67–3.62) | 0.31 | 1.79 | (0.75–4.26) | 0.19 |
120 ≤ SBP < 130* | 10/45 | Ref |  |  | Ref |  |  | |
130 ≤ SBP < 140 | 20/70 | 1.71 | (0.79–3.68) | 0.17 | 1.66 | (0.75–3.67) | 0.21 | |
SBP ≥ 140 | 73/232 | 1.54 | (0.79–2.99) | 0.2 | 1.78 | (0.9–3.53) | 0.1 | |
Untreated (N = 1049) | SBP < 120 | 29/361 | 0.92 | (0.54–1.56) | 0.75 | 0.92 | (0.54–1.57) | 0.77 |
120 ≤ SBP < 130* | 26/215 | Ref |  |  | Ref |  |  | |
130 ≤ SBP < 140 | 40/183 | 1.64 | (1.0–2.71) | 0.049 | 1.34 | (0.81–2.23) | 0.25 | |
SBP ≥ 140 | 95/290 | 1.88 | (1.21–2.91) | 0.005 | 1.81 | (1.16–2.83) | 0.009 | |
Total (N = 1448) | DBP < 80 | 136/640 | 1.79 | (1.22–2.65) | 0.003 | 1.68 | (1.13–2.5) | 0.01 |
 | 80 ≤ DBP < 85* | 32/276 | Ref |  |  | Ref |  |  |
 | 85 ≤ DBP < 90 | 40/194 | 1.85 | (1.16–2.96) | 0.009 | 1.78 | (1.12–2.85) | 0.015 |
 | DBP ≥ 90 | 97/338 | 2.66 | (1.78–3.98) | <0.001 | 2.77 | (1.85–4.15) | <0.001 |
Treated (N = 399) | DBP < 80 | 43/120 | 2.92 | (1.42–6.02) | 0.004 | 2.73 | 1.3–5.7) | 0.008 |
80 ≤ DBP < 85* | 9/76 | Ref |  |  | Ref |  |  | |
85 ≤ DBP < 90 | 12/56 | 1.99 | (0.84–4.74) | 0.12 | 2.02 | (0.84–4.88) | 0.11 | |
DBP ≥ 90 | 51/147 | 3.68 | (1.81–7.5) | <0.001 | 4.53 | (2.21–9.3) | <0.001 | |
Untreated (N = 1049) | DBP < 80 | 93/520 | 1.47 | (0.93–2.33) | 0.1 | 1.41 | (0.88–2.26) | 0.15 |
80 ≤ DBP < 85* | 23/200 | Ref |  |  | Ref |  |  | |
85 ≤ DBP < 90 | 28/138 | 1.88 | (1.08–3.27) | 0.025 | 1.88 | (1.07–3.28) | 0.027 | |
DBP ≥ 90 | 46/191 | 2.25 | (1.36–3.72) | 0.001 | 2.17 | (1.3–3.61) | 0.003 | |
Total (N = 1448) | PP < 39* | 28/363 | Ref |  |  | Ref |  |  |
39 ≤ PP < 51 | 57/382 | 1.41 | (0.9–2.23) | 0.13 | 1.27 | (0.8–2.02) | 0.3 | |
51 ≤ PP < 65 | 91/346 | 1.79 | (1.16–2.76) | 0.008 | 1.51 | (0.97–2.33) | 0.06 | |
PP ≥ 65 | 129/357 | 1.94 | (1.26–2.97) | 0.002 | 1.71 | (1.11–2.63) | 0.014 | |
Treated (N = 399) | PP < 49* | 24/109 | Ref |  |  | Ref |  |  |
49 ≤ PP < 60 | 28/94 | 1.27 | (0.72–2.22) | 0.4 | 1.29 | (0.73–2.28) | 0.34 | |
60 ≤ PP < 74 | 33/99 | 1.03 | (0.6–1.78) | 0.9 | 0.91 | (0.52–1.59) | 0.76 | |
PP ≥ 74 | 30/97 | 0.88 | (0.5–1.54) | 0.65 | 0.84 | (0.48–1.48) | 0.54 | |
Untreated (N = 1049) | PP < 39* | 18/279 | Ref |  |  | Ref |  |  |
 | 39 ≤ PP < 48 | 22/263 | 0.88 | (0.47–1.64) | 0.68 | 0.66 | (0.35–1.26) | 0.21 |
 | 48 ≤ PP < 61 | 56/256 | 1.7 | (0.99–2.93) | 0.05 | 1.22 | (0.7–2.14) | 0.48 |
 | PP ≥ 61 | 94/251 | 2.18 | (1.29–3.69) | 0.003 | 1.83 | (1.07–3.12) | 0.027 |